<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Bioequivalence Recommendations for Risperidone Injection; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Bioequivalence Recommendations for Risperidone Injection; Availability</h1>
    <p class="timestamp">Published: 2013-08-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry entitled "Draft Guidance on Risperidone." The guidance provides specific recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for risperidone injection.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-20696</p>
    <p><strong>Publication Date:</strong> 2013-08-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/08/26/2013-20696/draft-guidance-for-industry-on-bioequivalence-recommendations-for-risperidone-injection-availability">https://www.federalregister.gov/documents/2013/08/26/2013-20696/draft-guidance-for-industry-on-bioequivalence-recommendations-for-risperidone-injection-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-20696</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
